These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1783991)

  • 21. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onset-potency relationship of nondepolarizing muscle relaxants: a reexamination using simulations.
    Bhatt SB; Amann A; Nigrovic V
    Can J Physiol Pharmacol; 2007 Aug; 85(8):774-82. PubMed ID: 17901887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of parametric with semiparametric analysis of the concentration versus effect relationship of metocurine in dogs and pigs.
    Shafer SL; Varvel JR; Gronert GA
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):291-304. PubMed ID: 2810069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
    Savarese JJ; Lien CA; Belmont MR; Wastila WB
    Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of neuromuscular blocking agents.
    Fisher DM
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of neuromuscular blocking drugs on arterial pressure and heart rate in rats.
    Ertama PM; Paakkari I; Paakkari P; Karppanen H
    Med Biol; 1984; 62(4):231-8. PubMed ID: 6151034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered i.v.
    Weatherley BC; Williams SG; Neill EA
    Br J Anaesth; 1983; 55 Suppl 1():39S-45S. PubMed ID: 6688016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent.
    van den Broek L; Lambalk LM; Richardson FJ; Wierda JM
    Anesth Analg; 1991 Jun; 72(6):811-6. PubMed ID: 1674648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011.
    Savarese JJ; McGilvra JD; Sunaga H; Belmont MR; Van Ornum SG; Savard PM; Heerdt PM
    Anesthesiology; 2010 Jul; 113(1):58-73. PubMed ID: 20526187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Muscle relaxants. New substances and neuromuscular monitoring].
    Diefenbach C; Nigrovic V; Mellinghoff H; Buzello W
    Anaesthesist; 1997 Jan; 46(1):3-13. PubMed ID: 9082865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the onset and clinical duration of high doses of cisatracurium and rocuronium.
    Lighthall GK; Jamieson MA; Katolik J; Brock-Utne JG
    J Clin Anesth; 1999 May; 11(3):220-5. PubMed ID: 10434218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.
    Kopman AF; Klewicka MM; Kopman DJ; Neuman GG
    Anesthesiology; 1999 Feb; 90(2):425-31. PubMed ID: 9952148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of "priming" on the potency of non-depolarizing neuromuscular blocking agents.
    Brady MM; Mirakhur RK; Gibson FM
    Br J Anaesth; 1987 Oct; 59(10):1245-9. PubMed ID: 2890366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic analysis of the effect of vecuronium in surgical patients: pharmacokinetic and pharmacodynamic modeling without plasma concentrations.
    Warwick NR; Graham GG; Torda TA
    Anesthesiology; 1998 Apr; 88(4):874-84. PubMed ID: 9579494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
    Kopman AF
    Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The dose-response relationship and time course of the neuromuscular blockade by alcuronium].
    Pühringer F; Adler R; Mitterschiffthaler G; Koller J; Mair P; Khünl-Brady KS; Agoston S
    Anaesthesist; 1990 Oct; 39(10):508-12. PubMed ID: 1980578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
    Mirakhur RK
    Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.